Skip to main content Back to Top
Advertisement

4/3/2026

Diazepam Injection

Products Affected - Description

    • Diazepam injection, Pfizer, 5 mg/mL, 2 mL Carpuject syringe, 10 count, NDC 00409-1273-32

Reason for the Shortage

    • Dr. Reddy's has diazepam injection available.
    • Fresenius Kabi has diazepam injection available.
    • Hikma has diazepam injection available.
    • Natco has diazepam injection available.
    • Pfizer has diazepam injection on shortage due to manufacturing delays.

Available Products

    • Diazepam injection, Dr. Reddy's, 5 mg/mL, 2 mL syringe, 10 count, NDC 43598-0106-10
    • Diazepam injection, Fresenius Kabi, 5 mg/mL, 2 mL Simplist syringe, 24 count, NDC 76045-0204-20
    • Diazepam injection, Hikma, 5 mg/mL, 10 mL vial, 10 count, NDC 00641-6243-10
    • Diazepam injection, Hikma, 5 mg/mL, 2 mL syringe, 10 count, NDC 00641-6244-10
    • Diazepam injection, Natco, 5 mg/mL, 10 mL vial, 5 count, NDC 69339-0137-05
    • Diazepam injection, Natco, 5 mg/mL, 2 mL Luer Lock syringe, 10 count, NDC 69339-0137-34
    • Diazepam injection, Pfizer, 5 mg/mL, 10 mL vial, 10 count, NDC 00409-3213-12

Estimated Resupply Dates

    • Pfizer has diazepam 5 mg/mL 2 mL Carpuject syringes in limited supply with weekly releases.

Safety

    • Pfizer, in coordination with FDA, issued an Important Drug Warning Letter regarding a potential molding defect at the tip of the needle sheath. Visually examine Carpuject® units prior to administration and discard any unit showing a hole at the tip of the needle sheath as shown in pictures at https://www.pfizerhospitalus.com/sites/default/files/news_announcements/Issued%20Carpuject%20DHCPL%2027MAR2026.pdf.

Updated

Updated April 3, 2026 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 11, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2026, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT